- The progressive loss of renal function in focal segmental glomerulosclerosis (FSGS) was reduced by half in the DAPA-CKD study…
- There is now evidence of how SGLT2 inhibitors slow the progression of chronic kidney disease, regardless of diabetes status…
- Iptacopan, an oral, alternative complement pathway inhibitor of Factor B, could provide the first therapy targeted at one of the key drivers of IgAN…
- The selective C5a receptor inhibitor avacopan could be used in future to treat immune-mediated inflammatory disorders in C3G renal disease.
- [PRESSWIRE] Italy – 05 June, 2021 — One in ten adults in Europe has reduced kidney function. It is a cruel fact that many of those affected do not notice their progressive renal insufficiency.
- [PRESSWIRE] Italy – 05 June, 2021 — That viruses and bacteria can trigger autoimmune processes is well known. In autoimmune disease, the immune system attacks the body’s own cells, which can become life-threatening, for example in lupus nephritis.
- [PRESSWIRE] Italy – 05 June, 2021 — It was realized early on in the pandemic that kidney values can predict a severe COVID-19 course [1]. The German S3 guidelines for inpatient treatment [2] therefore advise that urine and kidney values be measured on admission to the accident and emergency unit.
- [PRESSWIRE] Italy – 05 June, 2021 — Renal tropism or virus detection can be associated with severe course, greater incidence of acute kidney injury (AKI) and earlier death – yet the immediate role of the virus in the kidney has not been clarified.
- [PRESSWIRE] Parma, Italy – 05 May, 2021 — One in ten adults in Europe suffer from reduced kidney function and yet many will be unaware of this. What is fatal is that the loss of kidney function cannot be reversed. It is therefore essential that the general public are made aware of the importance of the kidneys and how to protect them.
- [PRESSWIRE] Austria – 04 May, 2021 — CEBINA GmbH, an Austrian biotech company, today announces that azelastine, previously identified as a potential anti-COVID-19 drug, is equally potent against newly emerging dominant variants of SARS-CoV-2 compared to the original virus. Azelastine is available as an anti-allergy nasal spray and is currently being tested in a Phase 2 efficacy trial for the treatment of early-stage COVID-19 disease.
- [PRESSWIRE] Brussels – 22.03.21 — One year after the start of the corona pandemic, the city network Eurocities invites everyone to a European minute of silence. The joint commemoration takes place next Wednesday, 24 March, at 12:00 noon CET.
- [PRESSWIRE] GERMANY – 01 March, 2021 — Advances in healthcare IT will be unveiled by Konica Minolta at the European Congress of Radiology Virtual Exhibition from March 3-10. Taking centre stage will be the launch of AeroDR X90, a high-end auto positioning X-ray system, and Sonimage HS2, a premium portable ultrasound device, as well as Exa Enterprise Imaging offering full diagnostic toolsets and viewing capabilities.
- [PRESSWIRE] NOBLESVILLE, Indiana – February 22, 2021 -— B Medical Systems, a Luxembourg-based manufacturer of medical device registered refrigeration and cold transport solutions, announced today that they have been awarded a group purchasing agreement with Premier. Effective April 1, 2021, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for B Medical Systems’ products and solutions in the General Laboratory Products, Equipment, and Service Category.
- [PRESSWIRE] London, UK – 18 February, 2021 — Obesity has been proven to increase the risk of death from Covid – now a leading specialist is offering a solution.
- [PRESSWIRE] Vienna, Austria – 17 February, 2021 — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts around the world are focusing on identifying new anti-COVID therapeutics that includes re-evaluation of existing product portfolios with a view to re-purpose drugs that have antiviral properties.
- [PRESSWIRE] Madrid, Spain – 25 January, 2021 — An innovative new technology from Necenti Labs offers 96% accuracy for COVID-19 detection before infection with deep data to give companies and individuals the power of knowledge to battle lockdown.
- [PRESSWIRE] SANTA ANA, January 26, 2021 — Airionex, the leading global provider of bi-polar ionization air and surface purification technology, announced today that it has hired Françoise Parker as Senior Vice President of Sales and Marketing. Françoise will report to CEO Jukka Matikka, and will be responsible for sales team leadership, accelerating Airionex revenue throughout North America, the development and management of key channels, and overseeing the company’s marketing strategy.
- [PRESSWIRE] Australia – 08 January, 2020 — A study carried out at the end of October by the University of Bern, Switzerland, certified that the masks with nano copper particles patented by the Chilean science-fashion company, The Copper Company, eliminate 85% of the SARS-CoV-2 in 5 minutes and, in 2 hours, up to 95%.
- [PRESWIRE] Russia – 29 December, 2020 — Lately, experts around the globe, and especially in Europe, have been actively raising regarding the right of the public to have access to medical treatment and diagnosis information regarding politicians and political cases.
- [PRESSWIRE] Germany – 21 December, 2020 — N-PATH is the most innovative European training course in interventional nephrology funded by European Commission in the framework of the Erasmus+ program coordinated by the University of Bari, in collaboration with the European Renal Association (ERA-EDTA), the Vascular Access Society, important international academic centers and two companies specialized in medical training.
- [PRESSWIRE] Denmark – 14 December, 2020 — Many challenges are associated with the conventional eye drop bottle. The global ophthalmic industry has long pushed for a way to better deliver medication to the eye. Now, the Danish-based MedTech start-up, EYE-GO, has the solution that can improve the lives of millions of people globally suffering from dry eyes and other chronic eye conditions. Leading ophthalmologists and frontrunning international players in the industry have already named it “a true game-changer in eye care”. The Danish state participated in the latest funding round.
- [PRESSWIRE] UK – 18.11.20 — Hundreds of religious leaders from around the world gather to pray for the end of COVID-19 ahead of a group plasma donation by 4,000 Shincheonji members…
- [PRESSWIRE] CA, US – 18 September, 2020 — Airionex announced today the results of new independent testing. Varionix® active bipolar ionization air cleaning technology from Airionex has been verified to be effective for disinfecting coronavirus from the air. The virus was completely eliminated within minutes.
- [PRESSWIRE] Parma, Italy – August 31, 2020 — Two randomized controlled studies show: SGLT2 inhibitors can slow chronic kidney disease (CKD) progression in all patients, not only in diabetics. Results of one study [1] were presented at the virtual ESC Congress 2020 and the results of the other were published in NEJM [2].
- [PRESSWIRE] Israel – 13 August, 2020 — Kanabo Research LTD und Simply Green BV haben eine exklusive Vertriebsvereinbarung unterzeichnet, um die medizinische Verdampfungstechnologie von Kanabo auf den deutschen Markt zu bringen. Im Rahmen der Vereinbarung erhält Simply Green das exklusive Vertriebsrecht für die proprietäre Lieferplattform Kanabo VapePod® und Rezepturen über dessen Vertriebsnetz.
- [PRESSWIRE] SECAUCUS, N.J., April 21, 2020 — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has begun to perform antibody testing for coronavirus (COVID-19) using blood samples. With the new service, Quest Diagnostics now provides healthcare providers in the United States access to COVID-19 antibody as well as molecular diagnostic laboratory testing.
- [PRESSWIRE] ALBANY, New York, June 9, 2020 — Video telemedicine has become an integral part of remote health care services, gaining popularity due to their use in chronic disease management, driving the evolution of the video telemedicine market. In the light of emerging coronavirus disease (COVID-19) pandemic and subsequent social distancing restrictions, video telemedicine services have become a necessity for a substantial portion of patient populations, especially in disease diagnosis.
- [PRESSWIRE] Vienna – 4 June, 2020 — The Austrian biotech company CEBINA GmbH announces that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale efforts offering short-, mid- and longer-term solutions to fight the COVID-19 pandemic. This seed funding will support proof-of-concept studies of the vaccine that will allow progress to pre-clinical development, scheduled for Q1/2021. The funds are provided by the Blom Family Office.
- [PRESSWIRE] Luxembourg – 14 May, 2020 — The pandemic has taken the medical world by surprise and challenged the medical device industry, putting a heavy strain on manufacturers. How does a CEO juggle between the intensifying demand for reliable medical equipment, the need for innovations, and the safety of his employees to make sure that COVID-19 is behind us in the shortest time possible?
- [PRESSWIRE] Austria – 20 April, 2020 — Austrian biotech company Calyxha Biotechnologies GmbH is pleased to announce the grant of European Patent No. EP3383381. This patent covers the use of calixarene compounds for neurodegenerative diseases, including Parkinson’s disease. It represents the company’s first granted patent, with prosecution of the corresponding patent applications ongoing in other territories.